Cross-fund · 4 holders
DMAC
DIAMEDICA THERAPEUTICS INC
CUSIP 25253X207
4
Tracked holders
$25.8M
Aggregate value
3,689,023
Shares
4
Active funds
Funds holding DMAC
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $12.6M | — | -44,712 | -2.4% |
| Millennium | Multi-Strategy | Q1 2026 | $6.3M | — | +167,032 | +21.7% |
| Vanguard | Institutional | Q4 2025 | $5.8M | — | +58,545 | +8.8% |
| Citadel | Multi-Strategy | Q1 2026 | $1.2M | — | +22,787 | +15.1% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.